Skip to main content

Building

A better future

through education, skill development and research

LEARN MORE

Healthy Diet May Lower Eye Disease Risk

An analysis of recent high-quality research reveals that diet may affect individuals’ risks related to the development and progression of age-related macular degeneration (AMD). The findings are published in Clinical & Experimental Ophthalmology.

Wednesday, July 4, 2018 11:12 am EDT
"Improving the quality of the diet, increasing the intake of foods that contain the nutrients required by the retina. and avoiding foods that induce oxidative damage will play an important role in protecting against AMD"

An analysis of recent high-quality research reveals that diet may affect individuals’ risks related to the development and progression of age-related macular degeneration (AMD). The findings are published in Clinical & Experimental Ophthalmology.

The systematic review included the analysis of 18 high-quality studies. Adherence to a Mediterranean diet was linked with a decreased risk of AMD progression. An Oriental diet pattern (with higher intake of vegetables, legumes, fruit, whole grains, tomatoes, and seafood) had decreased association with AMD prevalence, whereas a Western diet pattern (with higher intake of red meat, processed meat, high-fat dairy products, fried potatoes, refined grains and eggs) had increased association with AMD prevalence.

High consumption of vegetables rich in carotenoids and fatty fish containing omega-3 fatty acids was beneficial for those at risk of AMD. High glycaemic index diets and alcohol consumption of greater than two drinks a day had increased association with AMD.

"Improving the quality of the diet, increasing the intake of foods that contain the nutrients required by the retina. and avoiding foods that induce oxidative damage will play an important role in protecting against AMD," said lead author Naoko Chapman, of the University of Auckland, in New Zealand.

Additional Information

Link to Study: http://onlinelibrary.wiley.com/doi/10.1111/ceo.13343

About Journal 

Clinical & Experimental Ophthalmology is the official journal of The Royal Australian and New Zealand College of Ophthalmologists. The journal publishes peer-reviewed original research and reviews dealing with all aspects of clinical practice and research which are international in scope and application. CEO recognises the importance of collaborative research and welcomes papers that have a direct influence on ophthalmic practice but are not unique to ophthalmology.

The acceptance criteria for all papers are the quality, originality and significance of the research. Manuscripts are peer reviewed in an average time of 6 weeks, and accepted manuscripts are published online in an average of 7 days from receipt at the publishers. The Editorial Board reserves the right to refuse any material for publication and advises that authors should retain copies of submitted manuscripts, figures and correspondence, as material cannot be returned. Final acceptance or rejection rests with the Editorial Board.

Formerly known as the Australian and New Zealand Journal of Ophthalmology.

About Wiley 

Wiley, a global research and learning company, helps people and organizations develop the skills and knowledge they need to succeed. Our online scientific, technical, medical, and scholarly journals, combined with our digital learning, assessment and certification solutions help universities, learned societies, businesses, governments and individuals increase the academic and professional impact of their work. For more than 210 years, we have delivered consistent performance to our stakeholders. The company's website can be accessed at www.wiley.com.

Multimedia Files:

Preview image

Contact:

Penny Smith
Tel: +44 (0)1243 770448
sciencenewsroom@wiley.com

Business Wire NewsHQsm